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Abstract
Complex diseases are generally thought to be under the influence of multiple, and possibly
interacting, genes. Many association methods have been developed to identify susceptibility genes
assuming a single-gene disease model, referred to as single-locus methods. Multilocus methods
consider joint effects of multiple genes and environmental factors. One commonly used method
for family-based association analysis is implemented in FBAT. The multifactor-dimensionality
reduction method (MDR) is a multilocus method, which identifies multiple genetic loci associated
with the occurrence of complex disease. Many studies of late onset complex diseases employ a
discordant sib pairs design. We compared the FBAT and MDR in their ability to detect susceptibility
loci using a discordant sib-pair dataset generated from the simulated data made available to
participants in the Genetic Analysis Workshop 14. Using FBAT, we were able to identify the effect
of one susceptibility locus. However, the finding was not statistically significant. We were not able
to detect any of the interactions using this method. This is probably because the FBAT test is
designed to find loci with major effects, not interactions. Using MDR, the best result we obtained
identified two interactions. However, neither of these reached a level of statistical significance. This
is mainly due to the heterogeneity of the disease trait and noise in the data.
Background
It is commonly believed that complex diseases are caused
not by single genes acting alone, but by multiple genes
interacting with one another. Due to the large number of
single-nucleotide polymorphisms (SNPs) available in a
genome-wide scan, the computational burden of testing
each locus for main effects and all possible pair-wise, 3-
way, and even higher-order interactions is overwhelming.
One approach is to first identify a smaller number of can-
didate SNPs, using linkage analysis or a candidate gene
approach. With a refined list, a more thorough statistical
analysis can be performed. At this second stage, a univar-
iate test is commonly used, which we refer to as single-
locus method. Family-based association tests (FBAT) are
used for pedigree data [1] and a chi-square test for case-
control data. When SNPs have large interaction effects,
but very small marginal effects in the population, the sin-
gle-locus method will result in low power for detecting
them.
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There are several multilocus approaches that consider
interactions of multiple genes and environmental factors
in identifying susceptibility loci for complex diseases [2-
5]. The multifactor-dimensionality reduction (MDR)
method [2] was developed specifically to detect higher-
order interactions among polymorphisms even when the
marginal effects are very small. This method assumes a
dichotomous trait. MDR is an extension of a combinato-
rial partitioning method [3]. It reduces the dimensionality
of multilocus information to improve the identification
of polymorphism combinations associated with disease
risk. Currently, MDR is applicable only for case-control
and discordant sib pair study designs. Investigators have
used MDR successfully in the identification of gene × gene
interactions in data from case-control studies of sporadic
breast cancer [2] and essential hypertension [6]. Previous
empirical studies have demonstrated that this method can
take advantage of the information available in case-con-
trol studies and thereby maximize the statistical power in
a given sample. This has been shown in the identification
of higher-order interactions in simulated data [2,7]. How-
ever, these tests are based on case-control data, not family-
based discordant sib pairs. Many studies of late onset
complex diseases, such as Alzheimer disease, use discord-
ant sib-pair designs because when the patients are diag-
nosed as affected in their 70s, their parents are usually not
alive. Our goal was to compare the ability of FBAT and
MDR to detect multiple susceptibility loci in family-based
discordant sib-pair data.
Methods
We chose to use to the simulated data provided to partic-
ipants in the Genetic Analysis Workshop 14 (GAW14). To
avoid analysis bias, we did the analysis without knowing
the real answers prior to the GAW14 conference. Because
we used simulated data with a fictitious trait, there were
no a priori candidate genes to consider, so we used a posi-
tional approach to identify candidate regions. First, we
performed linkage analysis using microsatellite markers
with GENEHUNTER-PLUS. Next, we identified candidate
regions near linkage peaks, and selected candidate SNPs
in these regions. Finally, we performed association analy-
ses on the candidate SNPs, using both FBAT and MDR.
Datasets
We used the simulated data from the country of Aipotu.
The Aipotu families were selected when at least two off-
spring were present who had P1, P2, or P3. We chose dis-
ease status for Kofendrerd Personality Disorder (KPD) as
the phenotype of interest. In order to get sufficient sample
size for MDR analysis, we combined five replicates
(REP001-005) of microsatellite marker and SNP data,
with 500 nuclear families. We first performed genome-
wide linkage analysis using microsatellite markers to iden-
tify candidate regions, then we selected SNPs in the candi-
date regions for the follow-up association analysis. To
simulate discordant sib-pair design, we randomly selected
410 discordant sib pairs (820 individuals), with one dis-
cordant sib pair from each family. This dataset was then
analysed using FBAT and MDR.
Linkage analysis
We performed multipoint linkage analysis on microsatel-
lite markers using GENEHUNTER-PLUS. This approach is
based upon 1-parameter allele sharing model [8], which
allows exact calculation of likelihoods and LOD scores.
There are 2 forms of the 1-parameter allele-sharing model,
a linear model and an exponential model. We applied an
exponential model to calculate the LOD score because it
has several nice properties when compared to the linear
model [8]. The LOD-score function can be used to con-
struct confidence regions for gene location. We used this
feature to identify the candidate regions for the follow-up
association analysis. The map provided by GAW14 was in
recombination fraction (rf) units, we also use rf as the unit
of analysis for the results.
Association analysis
All 29 SNPs were tested for Hardy-Weinberg Equilibrium
(HWE) to check the quality of the data. SNPs not in HWE
were removed from the analysis.
The FBAT program implements a series of family-based
association tests [1]. When testing for association in an
area of known linkage with data from multiple sibs in a
family or multiple families in a pedigree, the most appro-
priate test statistic is based upon the empirical variance.
Because we used a positional approach to establish candi-
date regions, our FBAT test statistics for SNPs were com-
puted using the empirical variance.
Multifactor-dimensionality reduction (MDR)
MDR [2] is a modification of the combinatorial partition-
ing method (CPM) [3]. It was developed specifically to
detect higher-order interactions among polymorphisms
that predict dichotomous trait variation, even when the
marginal effects are very small [9]. MDR reduces the
dimensionality of multilocus information to improve the
identification of polymorphism combinations associated
with disease risk. The general steps of MDR method are: 1)
partition the data into some number of equal parts for a
v-fold cross-validation (e.g., 10-fold, depending on the
sample size); 2) select a set of n candidate genetic and/or
discrete environmental factors from all factors; 3) repre-
sent the n factors and their multifactor classes (m geno-
types/locus means nm classes) in n-dimensional space; 4)
estimate the ratio (R) of the number of affected sibs (A) to
the number of unaffected sibs (U) within each multifactor
class. Each multifactor class in n-dimensional space is
labelled either as "high-risk," if R ≥ T (some threshold), orBMC Genetics 2005, 6:S146
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as "low-risk," if R <T, thereby reduces the n-dimensional
model to a uni-dimensional model. For balanced designs,
the threshold is usually set to 1:1. 5) All possible combi-
nations of n factors are evaluated sequentially for their
ability to classify affected and unaffected individuals in
the training data. The best n-factor model is selected. 6)
The independent test data from the v-fold cross-validation
is used to estimate the prediction error of the best model
selected in Step 5. Steps 1–6 are repeated v times with the
data split into v different training and testing sets.
We analyzed the SNP dataset using MDR as described
above, with an affected sibs-to-unaffected sibs threshold
ratio of 1 and 10-fold cross-validation. We conducted
exhaustive search of all possible 1- to 7-locus interactions.
Due to the fact that the number of possible combinations
is exponential to the number of loci tested for interaction,
it is computationally overwhelming to do an exhaustive
search of all higher order interactions. Cross-validation
consistency (CVC) was used as the statistic to select the
best model [9]. Empirical p-values of MDR results were
obtained by running 100 permutation tests.
Results
Linkage analysis
Four linkage peaks were identified in the multipoint link-
age analysis on chromosomes 1 (1.62 rf, LOD = 7.25, p =
3.73 × 10-9), chromosome 3 (2.9 rf, LOD = 14.3, p < 10-
14), chromosome 5 (0.058 rf, LOD = 7.3, p = 3.37 × 10-9)
and chromosome 9 (0.06 rf, LOD = 3.56, p = 2.55 × 10-5).
We used the 1-LOD score rule to get the 90% confidence
regions as candidate regions. Because there was no uni-
form map for microsatellite markers and SNPs, we
assumed two extreme scenarios in which either left ends
of the two maps align, or the right ends of the two maps
align, and then defined the combination of the candidate
regions in both situations as the final candidate regions.
We then selected the 29 SNPs (Table 1) in these regions
for association analysis using FBAT and MDR. Twenty-
nine SNPs were each given a number for reference in the
following comparison (Table 1).
Comparison of results from FBAT and MDR
All of the 29 SNP were in HWE (p > 0.05), so all of them
are included in the analyses. Based on real answers, four
susceptibility loci (D1 to D4) were within the candidate
regions; two susceptibility loci (D5 and D6) on chromo-
somes 10 and 2 were not in the candidate regions, hence
Table 1: 29 candidate SNPs identified by linkage peaks.
Chromosome 1 Chromosome 3 Chromosome 5 Chromosome 9
SNP Number SNP Number SNP Number SNP Number
C01R0047 1 C03R0275 10 C05R0378 17 C09R0763 23
C01R0048 2 C03R0276 11 C05R0379 18 C09R0764 24
C01R0049 3 C03R0277 12 C05R0380 19 (D3) C09R0765 25 (D4)
C01R0050 4 C03R0278 13 C05R0381 20 C09R0766 26
C01R0051 5 C03R0279 14 C05R0382 21 C09R0767 27
C01R0052a 6 (D1) C03R0280 15 C05R0383 22 C09R0768 28
C01R0053 7 C03R0281 16 (D2) C09R0769 29
C01R0054 8
C01R0055 9
aBold text indicates real susceptibility loci.
Table 2: Results of MDR analysis of 29 SNPs.
Number of factors 
considered
Best candidate model Susceptibility loci 
identified
Cross-validation 
consistency
Mean Classification 
error %
Mean Prediction error 
%
1 8 - 5 46.1 53.41
2 5, 12 - 4 43.88 52.01
3 5, 12, 14 - 3 40.51 50.12
4 4, 5, 19a, 24 D3 2 35.95 54.14
54 ,  5 ,  6, 10, 24 D1 2 28.54 54.10
6 4, 5, 6, 10, 16, 24 D1, D2 6 19.38 51.52
74 ,   6, 14, 16, 18, 19, 24 D1, D2, D3 3 10.95 50.44
aBold text indicates real susceptibility loci.BMC Genetics 2005, 6:S146
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were not included in the follow-up association analysis.
D1, D2, D3, and D4 were within the candidate regions,
but do not appear in the map. They are in the extra SNP
packets, which we did not order at the time of our analy-
sis. D1, D2, D3, and D4 cause disease via four 2-locus
interactions (D1–D2, D2–D3, D3–D4, and D1–D4). The
closest SNPs to the four susceptibility loci in our map (6th,
16th, 19th, and 25th) were referred to as D1 to D4 for our
purposes, unless otherwise noted. Using FBAT, we identi-
fied D4 (p = 0.043). However, after correcting for multiple
tests, it is not significant (p = 0.129, false discovery rate
(FDR) correction on chromosome 9). Using MDR, we did
not identify any of 1- to 7-locus models as significantly
different from the null hypothesis of no association.
According to cross-validation consistency, the MDR 6-
locus model was the best model (p  = 0.84) including
interaction of D1–D2 (Table 2). Compared with the
answers, our 7-locus model was the best model. Using this
model, we detected the interactions D1–D2 and D2–D3,
although only directionally.
Discussion
We compared FBAT and MDR in their ability to detect sus-
ceptibility loci using discordant sib-pair dataset generated
from GAW14 simulated data. Using FBAT, our most
promising finding was for one of the major loci, D4.
Using MDR, our most promising finding was a 7-locus
model including D1, D2, and D3. However, none of our
results reached a level of statistical significance allowing
us to reject the null hypothesis of no association.
Our family-based analysis using FBAT did not result in a
statistically significant association with any of the suscep-
tibility loci. This may be because the algorithm is designed
to find loci with main effects, not loci interacting with one
another, which was the case in the GAW14 simulation
dataset. It is also possible that when we randomly selected
discordant sib pairs, we lost power we would have had in
analyses using the full pedigree information.
There are several possible explanations for the lack of
power for MDR in these analyses. Heterogeneity may have
played a role. In the simulated data, there were four 2-
locus interactions (D1–D4, D1–D2, D2–D3, and D3–
D4); each interaction caused disease alone. It has been
shown by simulation that MDR has very limited power in
the presence of heterogeneity [9], ranging from 5% to
41%, regardless of the particular epistasis model. The
"Aipotu" families had P1, P2, or P3, each of which is
caused by one of the four interactions. This heterogeneity
may explain why we were unable to achieve statistical sig-
nificance using MDR. Restricting the analyses to clusters
of individuals with similar phenotypes prior to analysis
by MDR may be one way to overcome the limitation of
this method for dealing with genetic heterogeneity. All
SNPs were tested for pair-wise linkage disequilibrium
(LD). There was none present in the simulated sample.
Our results were not influenced by the presence of LD. The
best model with most susceptibility loci included (D1,
D2, D3). This model had the highest dimensionality (7-
locus) of all we tested. It may be that higher-dimensional
models may have to be tested in order to include all sus-
ceptibility loci. However, the combinatorial nature of
MDR makes it impractical to test very high-dimensional
models. Other statistical methods may be used to identify
a smaller set of candidate loci in order to leverage this ben-
efits this method offers. The final possible explanation for
our loss of power is our choice for the sampling scheme
and loci examined. Our candidate regions did not include
D5 or D6. These affected the penetrance of trait P2, which
was caused by interactions between D2–D3 or D3–D4.
Our sampling procedure randomly selected discordant
sib-pairs. In doing so, we omitted information from other
pedigree members.
Conclusion
MDR has been shown to be useful in the identification of
gene × gene interactions in real data from case-control
studies [2,6]. In order to examine the efficacy of this
method for a discordant sib-pair design we compared
FBAT and MDR using the GAW14 simulated data. We
found that neither FBAT nor MDR, with 1- to 7-locus
models, were able to detect the susceptibility loci in dis-
cordant sib-pair dataset. FBAT is designed to find loci with
main effects, not interactions, so we expected that we
would not detect interacting loci. Our MDR models did
not detect the susceptibility loci either, likely due to
genetic heterogeneity and our sample design. In most epi-
demiological studies, the genetic variations conferring lia-
bility for disease are unknown, and not all candidate
factors can be selected. Methods for dealing with hetero-
geneity may be successful when homogeneous sub-phe-
notypes can be defined. The candidate gene approach is
common, but there might still be hundreds to thousands
of candidate SNPs. Extra steps will likely be necessary to
reduce the number of SNPs examined for association.
MDR has been shown to be useful in case-control studies
when there is no heterogeneity, but has limited power
where heterogeneity is present [2,7]. We have shown that
the MDR approach does not have the power to detect
interactions in the presence of more complex heterogene-
ity in a discordant sib-pair dataset. However, our direc-
tional detection of two interactions (D1–D2, D2–D3) in
a 7-locus model may suggest that this approach might be
successful in other settings.
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